Abstract
The aim of this study was to evaluate whether a new low-cost strategy for the introduction of magnesium sulphate (MgSO4) for preeclampsia and eclampsia in low-resource areas will result in improved maternal and perinatal outcomes. Doctors and midwives from ten hospitals in Kano, Nigeria, were trained on the use of MgSO4. The trained health workers later conducted step-down trainings at their health facilities. MgSO4, treatment protocol, patella hammer, and calcium gluconate were then supplied to the hospitals. Data was collected through structured data forms. The data was analyzed using SPSS software. From February 2008 to January 2009, 1,045 patients with severe preeclampsia and eclampsia were treated. The case fatality rate for severe preeclampsia and eclampsia fell from 20.9 % (95 % CI 18.7–23.2) to 2.3 % (95 % CI 1.5–3.5). The perinatal mortality rate was 12.3 % as compared to 35.3 % in a center using diazepam. Introduction of MgSO4 in low-resource settings led to improved maternal and fetal outcomes in patients presenting with severe pre-eclampsia and eclampsia. Training of health workers on updated evidence-based interventions and providing an enabling environment for their practice are important components to the attainment of the Millenium Development Goals (MDG) in developing countries.
Similar content being viewed by others
References
United Nations. Millennium Development Goals. 2007 progress report 2007, http://mdgs.un.org/unsd/mdg/default.aspx. Accessed January 2011.
Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33(3), 130–137.
Khan, K. S., Wojdyla, D., Say, L., et al. (2006). WHO analysis of causes of maternal death: A systematic review. Lancet, 367, 1066–1074.
The Eclampsia Trial Collaborative Group. (1995). Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet, 345(8963), 1455–1463.
Tukur, J. (2009). The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Annals of African Medicine, 8, 76–80.
Langer, A., Viller, J., Tell, K., Kim, T., & Kennedy, S. (2008). Reducing eclampsia related deaths: A call to action. Lancet, 371, 705–706.
Ridge, L. A., Bero, L. A., & Hill, R. S. (2010). Identifying barriers to the availability and use of magnesium sulphate injection in resource poor countries: A case study in Zambia. BioMedical Central Health Services Research, 10, 340.
Sheith, S. S., & Chalmers, I. (2002). Magnesium for preventing and treating eclampsia: Time for international action. Lancet, 359, 1872–1873.
National Population Commission. (2006). Population and housing census of the Federal Republic of Nigeria. Available from http://www.population.gov.ng/images/stories/Priority%20Tables%20Volume%20I-update.pdf (Accessed July 14th 2011).
National Population Commission (NPC) and ICF Macro. (2008). Nigeria Demographic and Health Survey (NDHS). http://www.measuredhs.com/pubs/pdf/GF15/GF15.pdf.
Kombe, G., Fleisher, L., Kariisa, E., Arur, A., Sanjana, P., & Paina, L. et al. (April 2009). Nigeria health system assessment 2008. Abt Associates Inc.
Adamu, Y. M., Salihu, H. M., Sathiakumar, N., & Alexander, R. (2003). Maternal mortality in Northern Nigeria: A population based study. European Journal of Obstetrics, Gynaecology and Reproductive Biology, 109(2), 153–159.
Kullima, A. A., Kawuwa, M. B., Audu, B. M., Usman, H., & Geidam, A. D. (2009). A 5-year review of maternal mortality associated with eclampsia in a tertiary institution in northern Nigeria. Annals of African Medicine, 8(2), 81–84.
Tukur, J., Umar, B. A., & Rabi’u, A. (2007). Pattern of eclampsia in a tertiary health facility situated at a semi rural town in Northern Nigeria. Annals of African Medicine, 6(4), 164–167.
Onakewhor, J. U., & Gharoro, E. P. (2008). Changing trends in maternal mortality in a developing country. Nigerian Journal of Clinical Practice, 11(2), 111–120.
Eke, A. C., Ezebialu, U. I., & Okafor, C. (2011). Presentation and outcome of eclampsia at a tertiary center in South East Nigeria—A 6-year review. Hypertension in Pregnancy, 30, 125–132.
Tsu, V. D., & Shane, B. (2004). New and underutilized technologies to reduce maternal mortality: Call to action from a bellagio workshop. International Journal of Gynaecology and Obstetrics, 85(Suppl 1), S83–S93.
Firoz, T. et al. (2011). Pre-eclampsia in low and middle income countries. Best Practice & Research Clinical Obstetrics and Gynaecology. doi:10.1016/j.bpobgyn.2011.04.002.
Goldenberg, R. L., McClure, E. M., McGuire, E. R., Kamath, B. D., & Jobe, H. A. (2011). Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. International Journal of Gynaecology and Obstetrics, 113, 91–95.
Askie, L., Duley, L., Henderson-Smart, D., et al. (2007). Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet, 369, 1791–1798.
Hofmeyr, G. J., Atallah, A. N., & Duley, L. (2006). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, CD001059.
Melah, G. S., Massah, A. A., & El Nafaty, A. U. (2006). Pregnancy outcomes of women with eclampsia in Gombe, Nigeria. International Journal of Gynecology and Obstetrics, 92, 251–252.
Jabeen, M., Yakoob, M. Y., Imdad, A., & Bhutta, Z. A. (2011). Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BioMed Central Public Health, 11(Suppl 3), S6.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tukur, J., Ahonsi, B., Mohammed Ishaku, S. et al. Maternal and Fetal Outcomes After Introduction of Magnesium Sulphate for Treatment of Preeclampsia and Eclampsia in Selected Secondary Facilities: A Low-Cost Intervention. Matern Child Health J 17, 1191–1198 (2013). https://doi.org/10.1007/s10995-012-1105-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10995-012-1105-9